KATY, TX / ACCESSWIRE / February 9, 2021 / Neutra Corp. (OTC PINK:NTRR) ("Neutra" or "the Company") announces that its wholly owned subsidiary, VIVIS, has completed a major expansion of its in-house testing lab. This expansion greatly increases VIVIS' ability to test Neutra's hemp-based products for consistency, potency and quality; it also streamlines the company's manufacturing process to make it more efficient.
"VIVIS' lab expansion gives us a lot of positives going forward," said Neutra CEO Sydney Jim. "Quality is a hallmark of our brand. It's a strength that separates us from the competition in the minds of customers. This newly expanded lab will help us ensure our products remain of the highest quality and consistency. It will also help us better respond to increases in demand production-wise as we roll out more hemp-based CBD products in the years ahead."
Hemp-based CBD sales continue to be strong. Despite the ongoing COVID-19 pandemic - now approaching a year in duration - consumers kept buying CBD products at an increasing pace. Neutra responded to this market opportunity earlier in 2021 by hiring a national sales staff to reach out to a wider range of CBD retailers, including major chain stores. Recently the national sales team reported receiving a positive reception in initial meetings with several well-known retail outlets.
About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD-LOOKING STATEMENTS
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp.
View source version on accesswire.com:
https://www.accesswire.com/628420/VIVIS-Lab-Expansion-Boosts-In-House-Testing-Capabilities-Enhances-Neutras-Production-Process
